{"id":"W2074687456","doi":"10.1159/000095037","title":"A Review of Malignancies Observed during Efalizumab (Raptiva®) Clinical Trials for Plaque Psoriasis","year":2006,"lang":"en","type":"review","venue":"Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Population; Skin cancer; Placebo; Dermatology; Internal medicine; Clinical trial; Malignancy; Cancer; Gastroenterology; Plaque psoriasis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002284369,0.0008874224,0.01103491,0.0003289661,0.0001755185,0.000009766629,0.0006849632,0.002214273,0.0002523838],"category_scores_gemma":[0.002072447,0.0006653215,0.004181509,0.0003234781,0.0003225712,0.00006120017,0.0001534898,0.0004248836,0.0002632593],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007338994,"about_ca_system_score_gemma":0.0006035441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002966739,"about_ca_topic_score_gemma":0.00001629162,"domain_scores_codex":[0.9870318,0.006125177,0.005143929,0.0008949821,0.00005621747,0.0007478976],"domain_scores_gemma":[0.9899306,0.005604571,0.003273543,0.0009271743,0.0002124632,0.00005168473],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003165126,0.000431641,0.00007554475,0.2695544,0.005359097,0.00008117768,0.00002057036,3.554036e-8,0.00003588587,0.001064376,0.06082346,0.6622373],"study_design_scores_gemma":[0.003118316,0.0001134514,0.00002914987,0.05014714,0.008613247,0.001318818,0.000005919759,4.908771e-8,0.0003612718,0.00004815583,0.935726,0.0005184145],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001089494,0.991851,0.000045698,0.0001103603,0.002773783,0.003322454,0.001463558,0.0001065515,0.0002176276],"genre_scores_gemma":[0.00001763986,0.9932219,0.0002460555,0.0001339467,0.0002135901,0.001543828,0.003614453,0.00009413713,0.0009144611],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8749026,"threshold_uncertainty_score":0.9995798,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2664707127899108,"score_gpt":0.4162623924972009,"score_spread":0.1497916797072901,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}